Latest news, updates, and announcements from Neusignal Therapeutics.
Neusignal Therapeutics, a Tohoku University spinout developing a disease-modifying small-molecule drug for Alzheimer's-type dementia, announced on June 30 it has raised approximately 5.32 billion yen...
